AlBensonMD

Oncology • Chicago, IL

Professor in Medicine-Hematology/Oncology, Northwestern University Medical School

Join to view full profile

Dr. Benson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Benson's full profile

Already have an account?

Office
675 N Saint Clair St
Chicago, IL 60611
Phone+1 312-695-0990

Fax+1 312-695-6352
Is this information wrong?

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1981 - 1984
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1976 - 1979
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1976

Certifications & Licensure

IL State Medical License 1979 - 2026
WI State Medical License 1977 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FASCO) American Society of Clinical Oncologists, 2008
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed Start of enrollment: 1994 Mar 01
Completed
Phase 3
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas Start of enrollment: 1998 Jul 01
Completed
Phase 3
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Start of enrollment: 1998 Oct 01
Completed
Phase 3
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors Start of enrollment: 1999 Aug 01
Completed
Phase 1
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 1999 Aug 01
Completed
Phase 1
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Start of enrollment: 2000 Jan 01
Completed
Phase 1
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus Start of enrollment: 2000 Feb 01
Unknown status
Phase 2
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer Start of enrollment: 2003 Oct 15
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Start of enrollment: 2005 Sep 06
Active, not recruiting
Phase 3
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer Start of enrollment: 2006 May 11
Terminated
Phase 3
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer Start of enrollment: 2010 Jan 18
Completed
Phase 2
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery Start of enrollment: 2009 Aug 01
Completed
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours Start of enrollment: 2012 Sep 06
Completed
Phase 3
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
Active, not recruiting
Phase 2
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma Start of enrollment: 2014 Jul 23
Terminated
Phase 2
FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma Start of enrollment: 2017 Sep 21
Completed
Phase 2
Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma Start of enrollment: 2023 Jul 01
Recruiting
Phase 2, Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer.
Patrick McGarrah, Joleen Hubbard, Paul J Novotny, Megan E Branda, Daniel S Sargent, Roscoe F Morton, Charles S Fuchs, Al B Benson, Stephen K Williamson, Brian P Findla...> ;Cancer Control. 2023 Jun 20
5 citations
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
Lakshmi Rajdev, Ju-Whei Lee, Steven K Libutti, Al B Benson, George A Fisher Jr, Pamela L Kunz, Andrew E Hendifar, Paul Catalano, Peter J O'Dwyer> ;Investigational New Drugs. 2022 Dec 1
6 citations
A Framework for Harmonization of Radiomics Data for Multicenter Studies and Clinical Trials.
Moataz A S Soliman, Linda C Kelahan, Michael Magnetta, Hatice Savas, Rishi Agrawal, Ryan J Avery, Pascale Aouad, Benjamin Liu, Yue Xue, Young K Chae, Riad Salem, Al B ...> ;JCO Clinical Cancer Informatics. 2022 Nov 1
7 citations
Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.
Zhonglin Hao, Saurabh Parasramka, Quan Chen, Aasems Jacob, Bin Huang, Timothy Mullett, Al B Benson> ;The Oncologist. 2023 Jan 18
3 citations
Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma.
Casey M Silver, Rachel H Joung, Charles D Logan, Al B Benson, Devalingam Mahalingam, Michael I D'Angelica, David J Bentrem, Anthony D Yang, Karl Y Bilimoria, Ryan P Me...> ;Journal of Surgical Oncology. 2023 Jan 1
5 citations
Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort.
Aakash N Gupta, Andrew C Gordon, Ahmed Gabr, Aparna Kalyan, Sheetal M Kircher, Devalingam Mahalingam, Mary F Mulcahy, Ryan P Merkow, Anthony D Yang, David J Bentrem, J...> ;Cardiovascular and Interventional Radiology. 2022 Aug 1
1 citations
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase II...
Frank A Sinicrope, Qian Shi, Aurelie Catteau, Graham M Poage, Tyler J Zemla, Bernhard Mlecnik, Al B Benson, Sharlene Gill, Richard M Goldberg, Morton S Kahlenberg, Sur...> ;JCO Precision Oncology. 2022 Aug 1
1 citations
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
Richard M Goldberg, Richard Adams, Marc Buyse, Cathy Eng, Axel Grothey, Thierry André, Alberto F Sobrero, Stuart M Lichtman, Al B Benson, Cornelis J A Punt, Tim Maugha...> ;Journal of the National Cancer Institute. 2022 Jun 13
1 citations
Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).
Lee, S., Ma, C., Zhang, S., Ou, F., Bainter, T., Niedzwiecki, D., Saltz, L., Mayer, R., Whittom, R., Hantel, A., Benson, A., Atienza, D., Kindler, H., Gross, C., Irwin...> ;The Oncologist. 2022 Jun 8
47 citations
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research S...
Randall A Oyer, Patricia Hurley, Leigh Boehmer, Suanna Steeby Bruinooge, Kathryn Levit, Nadine Barrett, Al Benson, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jenn...> ;Journal of Clinical Oncology. 2022 Jul 1
14 citations
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
En Cheng, Fang-Shu Ou, Chao Ma, Donna Spiegelman, Sui Zhang, Xin Zhou, Tiffany M Bainter, Leonard B Saltz, Donna Niedzwiecki, Robert J Mayer, Renaud Whittom, Alexander...> ;Journal of Clinical Oncology. 2022 Mar 1
4 citations
Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative.
Brian C. Brajcich, Al B. Benson, Gerald Gantt, Oliver S. Eng, Robert W Marsh, Mary F. Mulcahy, Blase N. Polite, Benjamin D. Shogan, Anthony D. Yang, Ryan P. Merkow> ;Journal of Surgical Oncology. 2021 Nov 25
Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 (Gastric Cancer, (2021...
Eric Van Cutsem, Mayur Amonkar, Charles S. Fuchs, Maria Alsina, Mustafa Ozguroglu, Yung-Jue Bang, Hyun Cheol Chung, Kei Muro, Eray Goekkurt, Al B. Benson, Weijing Sun,...> ;Gastric Cancer. 2021 Nov 1
10 citations
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
Robin Kate Kelley, Nancy M. Joseph, Halla Sayed Nimeiri, Jimmy Hwang, Laura Kulik, Zoe Ngo, Spencer C. Behr, Courtney Onodera, Karen Zhang, Andrea Grace Bocobo, Al B. ...> ;Liver Cancer. 2021 Sep 1
1 citations
Clinical trials as a path toward equity.
Al B. Benson, Ruth C. Carlos> ;Cancer. 2021 Oct 15
6 citations
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061.
Eric Van Cutsem, Mayur Amonkar, Charles S Fuchs, Maria Alsina, Mustafa Özgüroğlu, Yung-Jue Bang, Hyun Cheol Chung, Kei Muro, Eray Goekkurt, Al B Benson 3rd, Weijing Su...> ;Gastric Cancer. 2021 Nov 1
3 citations
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers.
Julia R. Trosman, Christine B. Weldon, Bruce D. Rapkin, Al B. Benson, Della F. Makower, Su-Ying Liang, Swati Kulkarni, Claudia B. Perez, Shelly S. Lo, Editha A. Kruege...> ;JCO Oncology Practice. 2021 Aug 10
220 citations
Neuroendocrine and adrenal tumors, version 2.2021
Manisha H. Shah, Whitney S. Goldner, Al B. Benson, Emily K. Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, Jennifer A. Chan, Satya Das, Paxton V. Dickson, Paul T. F...> ;Journal of the National Comprehensive Cancer Network. 2021 Jul 28
409 citations
Hepatobiliary cancers, Version 2.2021
Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert A. Anders, Chandrakanth Are, Melinda Bachini, Mitesh J. Borad, Daniel B. Brown, Adam M. ...> ;Journal of the National Comprehensive Cancer Network. 2021 May 1
3 citations
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
, , , , , , , , , , , , , , , , , , , > ;JNCI Cancer Spectrum. 2021 Apr 12
3 citations
Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes...
Hilary Chan, Li Zhang, Michael A. Choti, Matthew H. Kulke, James C. Yao, Eric K. Nakakura, Mark Bloomston, Al B. Benson, Manisha H. Shah, Jonathan R. Strosberg, Emily ...> ;Pancreas. 2021 Apr 1
487 citations
Pancreatic adenocarcinoma, Version 2.2021
Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary, Stephen W. Behrman, Al B. Benson, Dana Backlund Cardin, E. Gabriela Chiorean, Vincent Chung, Brian G. Czi...> ;Journal of the National Comprehensive Cancer Network. 2021 Apr 1
4 citations
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group
Arturo Loaiza-Bonilla, Al B. Benson, Axel Grothey, Misagh Karimi, Samuel J. Klempner, Daniel Lin, Reshma Mahtani, Heloisa P. Soares> ;The Oncologist. 2021 Aug 1
691 citations
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi Jen Chen, Kristen K. Ciombor, Stacey Cohen, Harry S. Cooper, Dustin A. Deming, Linda Farkas, I...> ;Journal of the National Comprehensive Cancer Network. 2021 Mar 2
2 citations
An evaluation of RAS testing among metastatic colorectal cancer patients in the USA.
Laura Sangaré, Kimberly Delli-Zotti, Ana Florea, Marko Rehn, Al B. Benson, Kimberly Lowe> ;Future Oncology. 2021 Feb 25
Join now to see all

Journal Articles

Efficacy and Safety of Pembrolizumab or Pembrolizumab plus Chemotherapy vs Chemotherapy Alone for Patients with First-Line, Advanced Gastric Cancer
Al Benson, Zev A Wainberg, JAMA Oncology
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
William J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, Value in Health

Lectures

The World Conference on Interventional Oncology (WCIO 2012)
World Conference on Interventional Oncology, Chicago, Illinois - 6/14/2012

Authored Content

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingAugust 2018

Press Mentions

Association of Community Cancer Centers Releases 16 Abstracts This FallNovember 13th, 2020
Climbing the Pancreatic Cancer MountainApril 16th, 2019
A Blueprint to Advance Colorectal Cancer ImmunotherapiesOctober 24th, 2017
Join now to see all